Starpharma Holdings (Starpharma Holdings) Total Assets : $29.41 Mil (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Starpharma Holdings Total Assets?

Starpharma Holdings's Total Assets for the quarter that ended in Dec. 2023 was $29.41 Mil.

During the past 12 months, Starpharma Holdings's average Total Assets Growth Rate was -13.30% per year. During the past 3 years, the average Total Assets Growth Rate was 23.30% per year. During the past 5 years, the average Total Assets Growth Rate was 21.80% per year. During the past 10 years, the average Total Assets Growth Rate was 1.00% per year.

During the past 13 years, Starpharma Holdings's highest 3-Year average Total Assets Growth Rate was 93.20%. The lowest was -25.10%. And the median was 18.60%.

Total Assets is connected with ROA %. Starpharma Holdings's annualized ROA % for the quarter that ended in Dec. 2023 was -4.30%. Total Assets is also linked to Revenue through Asset Turnover. Starpharma Holdings's Asset Turnover for the quarter that ended in Dec. 2023 was 0.15.

Starpharma Holdings Total Assets Historical Data

The historical data trend for Starpharma Holdings's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starpharma Holdings Total Assets Chart

Starpharma Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Assets

Get a 7-Day Free Trial

33.93

26.97

55.99

46.50

34.96

Starpharma Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Assets	Get a 7-Day Free Trial															48.16	46.50	38.90	34.96	29.41

Starpharma Holdings Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Starpharma Holdings's Total Assets for the fiscal year that ended in Jun. 2023 is calculated as

Total Assets	=	Total Equity (A: Jun. 2023 )	+	Total Liabilities (A: Jun. 2023 )
	=	23.366	+	11.591
	=	34.96

Starpharma Holdings's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	23.06	+	6.346
	=	29.41

Starpharma Holdings (OTCPK:SPHRF) Total Assets Explanation

Total Assets is connected with ROA %.

Starpharma Holdings's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-1.384	/	( (34.957	+	29.406)	/ 2 )
	=	-1.384	/	32.1815
	=	-4.30 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Starpharma Holdings's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	4.817	/	( (34.957	+	29.406)	/ 2 )
=	4.817	/	32.1815
=	0.15

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Starpharma Holdings Total Assets Related Terms

Thank you for viewing the detailed overview of Starpharma Holdings's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Starpharma Holdings (Starpharma Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starpharma Holdings Ltd (OTCPK:SPHRF) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

SPHRY:USA PQ6:Germany SPL:Australia

Address

4-6 Southampton Crescent, Abbotsford, Melbourne, VIC, AUS, 3067

Website

https://www.starpharma.com

Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.